The Research On The Integration Of Value Chains Of Pharmaceutical Enterprises Under The Background Of New Medical Reform

The pharmaceutical industry is an important part of our national economy and is closely related to the health of the the people.Due to the pharmaceutical industry in China starts late,in such aspects as technology and talents and capital,there is still a considerable gap with developed countries.In recent years,China's pharmaceutical industry is undergoing an adjustment from barbaric growth to returning to rational growth.The resources integration of pharmaceutical companies penetrates into various links such as research and development,production,commerce and terminal,Many domestic pharmaceutical companies have achieved rapid expansion of scale and cultivation of their core competitiveness through strategic resource integration.In March 2009,the State Council launched a new medical reform policy,and the pharmaceutical industry ushered in a new round of industry reshuffle.In this context,national and regional leading enterprises have become industry integrators with strong channel advantages and financial strength.With the help of capital,rapid M&A expansion has continued to extend to the upstream and downstream of the industrial chain,and the industry concentration has been significantly improved.In order to deeply study the integration strategies and integration effects of pharmaceutical companies in the value creation process,this paper has carried out related research.Firstly,it sorts out the relevant literatures of value chain theory at home and abroad,and builds an analytical framework based on the theory of value chain integration.Then it analyzes the impact of the new medical reform policy environment on the development of pharmaceutical enterprises,and summarizes the integration of internal and external value chains of pharmaceutical enterprises in the context of medical reform.Strategy;Finally,this paper selects the Tasly Group as the research object,and evaluates the value-added effect of the value chain integration strategy on the enterprise by analyzing the financial indicators and constructing the comprehensive performance evaluation system.Through research,This paper has the following conclusions:(1)value chain analysis is an effective tool to innovate business models and enhance corporate value.The value chain composition of different industries is different and needs specific analysis.(2)The value chain integration strategy implemented by enterprises can be divided into internal value chain integration and external value chain integration.External value chain integration involves upstream and downstream extension of industries and horizontal mergers and acquisitions.The internal value chain involves the management of internal value-added links and the optimization of business processes.(3)With regard to the performance evaluation of value chain integration,involving financial and non-financial factors,this paper builds a comprehensive performance evaluation system based on principal component analysis,and draws the conclusion that value chain integration has a positive impact on corporate performance,However,the construction of the performance evaluation model is influenced by many factors.In order to obtain objective and reasonable results,it is necessary to further explore and improve the evaluation model.